Phase I Dose Escalation Trial of the Novel Proteasome Inhibitor Carfilzomib in Patients with Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

The proteasome complex degrades proteins involved in a variety of cellular processes and is a powerful therapeutic target in several malignancies. Carfilzomib is a potent proteasome inhibitor which induces rapid CLL cell apoptosis in vitro. We conducted a phase I dose-escalation trial to determine s...

全面介紹

Na minha lista:
書目詳細資料
發表在:Leuk Lymphoma
Main Authors: Awan, Farrukh T., Flynn, Joseph M., Jones, Jeffrey A., Andritsos, Leslie A., Maddocks, Kami J., Sass, Ellen J., Lucas, Margaret S., Chase, Weihong, Waymer, Sharon, Ling, Yonghua, Jiang, Yao, Phelps, Mitch A., Byrd, John C., Lucas, David M., Woyach, Jennifer A.
格式: Artigo
語言:Inglês
出版: 2015
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4835239/
https://ncbi.nlm.nih.gov/pubmed/25669927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1014368
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍